BamSEC and AlphaSense Join Forces
Learn More

Aadi Bioscience Inc.

NASDAQ: AADI    
Share price (1/6/25): $3.41    
Market cap (1/6/25): $84.0 million

Material Contracts Filter

EX-10.3
from 8-K 18 pages Form of Registration Rights Agreement
12/34/56
EX-10.2
from 8-K 70 pages Subscription Agreement by and Among Aadi Bioscience, Inc., and the Purchasers December 19, 2024
12/34/56
EX-10.1
from 8-K 16 pages Voting and Support Agreement
12/34/56
EX-10.4
from 10-Q 11 pages Transition Agreement and Release
12/34/56
EX-10.3
from 10-Q 11 pages Transition Agreement and Release
12/34/56
EX-10.2
from 10-Q 4 pages Certain Identified Information Marked With [***] Has Been Excluded From This Exhibit Because It Is Not Material and Is of the Type That the Registrant Treats as Private and Confidential Amendment No. 03 to Negotiated Purchase Order Terms and Conditions for Clinical and Commercial Product
12/34/56
EX-10.1
from 8-K 6 pages Aadi Bioscience, Inc. Retention Bonus Letter
12/34/56
EX-10.3
from 10-Q 4 pages Aadi Bioscience, Inc. Amended and Restated Outside Director Compensation Policy
12/34/56
EX-10.2
from 10-Q 14 pages Aadi Bioscience, Inc. Executive Employment Agreement
12/34/56
EX-10.1
from 10-Q 10 pages Amendment No. 02 to Negotiated Purchase Order Terms and Conditions for Clinical and Commercial Product
12/34/56
EX-10.4
from 8-K 11 pages Aadi Bioscience, Inc. 2023 Inducement Equity Incentive Plan Stock Option Agreement
12/34/56
EX-10.3
from 8-K 18 pages Aadi Bioscience, Inc. 2023 Inducement Equity Incentive Plan
12/34/56
EX-10.2
from 8-K 14 pages Aadi Bioscience, Inc. Executive Employment Agreement
12/34/56
EX-10.1
from 8-K 15 pages Aadi Bioscience, Inc. 2021 Equity Incentive Plan Restricted Stock Unit Agreement Notice of Restricted Stock Unit Grant
12/34/56
EX-10.21
from 10-K 5 pages Amendment 01 to Negotiated Purchase Order Terms and Conditions for Clinical and Commercial Product
12/34/56
EX-10.17
from 10-K 9 pages Aadi Bioscience, Inc. Amended and Restated Executive Employment Agreement
12/34/56
EX-10.4
from 10-K 10 pages Aadi Bioscience, Inc. Amended and Restated Executive Employment Agreement
12/34/56
EX-10.2
from 8-K 18 pages Form of Registration Rights Agreement
12/34/56
EX-10.1
from 8-K 41 pages Securities Purchase Agreement by and Among Aadi Bioscience, Inc., and the Purchasers September 22, 2022
12/34/56
EX-10.1
from 10-Q 23 pages Negotiated Purchase Order Terms and Conditions for Clinical and Commercial Product
12/34/56